![](/img/cover-not-exists.png)
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma
J. Sadones, A. Michotte, P. Veld, C. Chaskis, R. Sciot, J. Menten, E.J.R. Joossens, T. Strauven, L.A. D’Hondt, D. Sartenaer, S.F.E.H. Califice, K. Bierau, C. Svensson, J. De Grève, B. NeynsVolume:
45
Year:
2009
Language:
english
Pages:
154
DOI:
10.1016/j.ejca.2008.09.002
File:
PDF, 153 KB
english, 2009